secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2023-08-02T23:59:59+00:00
Accession:  0000064803-23-000032
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health Q2 rev +10%, EPS $1.48; lowers GAAP EPS guidance to $6.53-$6.75
--------------------------------------------------------------------------

- Revenue $88.9B, +10.3% YoY; GAAP diluted EPS $1.48 (down from $2.29); adj EPS $2.21 (down from $2.53).
- Full-year GAAP diluted EPS guidance cut to $6.53-$6.75 from $6.90-$7.12; adj EPS guidance confirmed $8.50-$8.70.
- Operating income $3.23B, down $1.44B YoY; adjusted operating income $4.48B down $521M.
- Completed Oak Street Health acquisition on May 2, 2023; returned $795M to shareholders via dividends in Q2.
- Year-to-date cash flow from operations $13.3B; reaffirmed FY cash flow guidance $12.5B-$13.5B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480323000032/0000064803-23-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480323000032/cvs-20230802.htm
  HTML page:      https://secwatch.observer/filing/0000064803-23-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer